Monte Rosa Therapeutics Boosts Talent to Accelerate Molecular‑Glue Drug Pipeline
Monte Rosa Therapeutics boosts its team with equity awards to fuel its molecular‑glue pipeline, aiming to transform disease treatment at the protein level.
2 minutes to read
